Pharma Industry Insights & Resources

Small Molecule API

You can rely on us for high-quality API synthesis, from process development through long-term supply. Our capabilities include complex organic synthesis, fermentation and bioprocessing up to 150,000-liter scale, milling and micronizing, process optimization and scale-up, and process industrialization.

Large Molecule Biologics

Embedded within Pfizer and backed by its scientific resources and a global manufacturing network, we deliver development expertise and global regulatory support for your large molecule biologics. For every customer, our approach means collaborative product technology transfers and commercial-scale manufacture.

Enviero Progesterone: Pfizer CentreOne’s Green-Chemistry Progesterone API

Enviero is the first-of-its-kind, a green-chemistry progesterone that represents a step change in progesterone API synthesis. Developed over 12 years, Enviero is manufactured via a proprietary biocatalytic process based on plant sterols that reduces waste, greenhouse gas emissions and the use of hazardous solvents.

Webinar | An Overview of the Main Regulatory Issues Affecting the Pharmaceutical Industry

With the existence of a wide variety of regulatory approaches in the different knowledge areas, it becomes a priority to encourage regulatory harmonization.

Case Study | How Intelligent Collaboration Transformed a Generic into a Best-in-Class New Drug

Read how collaboration and the drive to find a workable solution led to a successful drug development program.

A Beginner’s Guide to Technology Transfers

At the beginning of any commercial relationship with a CDMO, there is a technology transfer. Over the product lifecycle this may occur with other external partners and a product’s continued success can depend upon it.

Q&A with Pfizer CentreOne's CEO Andrew Moore - Pharmaceutical Technology

The new GM of Pfizer CentreOne Andrew Moore sat down with Pharmaceutical Technology to discuss his career, vision for the business and what excites him most about his new role.

The Importance of End-To-End Thinking During Drug Product Development - Outsourced Pharma

Throughout a drug product development program it is important to build robustness and flexibility into the manufacturing process. In this article, Dr.

Pfizer CentreOne's Regulatory Affairs team named a finalist of CPhI Excellence in Pharma Awards

Pfizer CentreOne's Regulatory Affairs team led by Chris Rojewski has been named as a finalist for the CPhI Excellence in Pharma Awards, Regulatory Procedures and Compliance category.

General Capabilities

Welcome to Pfizer CentreOne. We’re a global CDMO embedded within Pfizer and a leading supplier of specialty APIs. Working with our customers, we combine our technical and commercial knowledge with open dialogue to solve challenges – we call this intelligent collaboration.

Making the Medicine Go Down: Specialized Oral Solids Delivery Technologies

Most oral solids formulations are designed to release the drug immediately after swallowing for rapid absorption into the bloodstream.

Pfizer CentreOne's Partnership Promise

Strong commercial partnerships are based on trust and lasting relationships. For this reason, organizational changes can be unsettling. What will the new leader bring? What impact will the change have on my partnership? These are valid questions that should be addressed.